Pdt Partners, LLC Ab Cellera Biologics Inc. Transaction History
Pdt Partners, LLC
- $1.02 Billion
- Q3 2024
A detailed history of Pdt Partners, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 64,304 shares of ABCL stock, worth $177,479. This represents 0.02% of its overall portfolio holdings.
Number of Shares
64,304
Previous 238,188
73.0%
Holding current value
$177,479
Previous $705,000
76.45%
% of portfolio
0.02%
Previous 0.07%
Shares
8 transactions
Others Institutions Holding ABCL
# of Institutions
153Shares Held
109MCall Options Held
153KPut Options Held
194K-
Baker Bros. Advisors LP New York, NY27.5MShares$76 Million0.76% of portfolio
-
Baillie Gifford & CO12.9MShares$35.6 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$29.3 Million0.03% of portfolio
-
Prosight Management, LP Dallas, TX9.08MShares$25.1 Million6.31% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.59MShares$12.7 Million0.0% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $787M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...